Document
IPR2023-00724, No. 116 Order Denying Director Review of Institution Decision - Order Denying Director Review of Institution Decision (P.T.A.B. Oct. 24, 2024)
Cite Document
IPR2023-00724, No. 116 Order Denying Director Review of Institution Decision - Order Denying Director Review of Institution Decision (P.T.A.B. Oct. 24, 2024)
+ More Snippets
Document
IPR2024-00009, No. 19 Institution Decision Joined - Decision Granting Institution of Inter Partes Review Granting Motion for Joinder (P.T.A.B. Apr. 25, 2024)
Cite Document
IPR2024-00009, No. 19 Institution Decision Joined - Decision Granting Institution of Inter Partes Review Granting Motion for Joinder (P.T.A.B. Apr. 25, 2024)
+ More Snippets
Document
IPR2023-00724, No. 99 Order Other - Amended Order Setting Oral Argument 37 CFR 4270 (P.T.A.B. Sep. 12, 2024)
Cite Document
IPR2023-00724, No. 99 Order Other - Amended Order Setting Oral Argument 37 CFR 4270 (P.T.A.B. Sep. 12, 2024)
+ More Snippets
Document
IPR2023-00724, No. 88 Order Other - Order Conduct of the Proceeding 37 CFR sec 425 (P.T.A.B. Aug. 26, 2024)
Cite Document
IPR2023-00724, No. 88 Order Other - Order Conduct of the Proceeding 37 CFR sec 425 (P.T.A.B. Aug. 26, 2024)
+ More Snippets
Document
IPR2024-00009, No. 16 Order on Motion - ORDER Conduct of the Proceeding 37 CFR § 425 (P.T.A.B. Mar. 29, 2024)
Cite Document
IPR2024-00009, No. 16 Order on Motion - ORDER Conduct of the Proceeding 37 CFR § 425 (P.T.A.B. Mar. 29, 2024)
+ More Snippets
Document
IPR2023-00724, No. 78 Order Other - ORDER Setting Oral Argument (P.T.A.B. Aug. 14, 2024)
Cite Document
IPR2023-00724, No. 78 Order Other - ORDER Setting Oral Argument (P.T.A.B. Aug. 14, 2024)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 24 (N.D.W.Va. May. 9, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 24 (N.D.W.Va. May. 9, 2022)
+ More Snippets
Document
IPR2024-00631, No. 8 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Mar. 12, 2024)
Cite Document
IPR2024-00631, No. 8 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Mar. 12, 2024)
+ More Snippets
Document
IPR2023-00724, No. 69 Order on Motion - ORDER Conduct of the Proceeding 37 CFR §§ 425 (P.T.A.B. Jul. 26, 2024)
Cite Document
IPR2023-00724, No. 69 Order on Motion - ORDER Conduct of the Proceeding 37 CFR §§ 425 (P.T.A.B. Jul. 26, 2024)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 17 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 17 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 16 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 16 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
+ More Snippets